FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Avinger, Inc. receives FDA clearance of the Pantheris system”
Avinger, Inc. (NASDAQ: AVGR) surged over 36% in premarket trading after the company received FDA clearance of the Pantheris system.
The receipt of the FDA clearance for a new clinical indication for the Pantheris image-guided atherectomy system allows the company to directly market Pantheris for the treatment of in-stent restenosis (ISR) in the lower extremity arteries.
Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot and Tigereye™ family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California.
For more information, please visit: Avinger, Inc.
About The Buzz: A Financial Buzz Show on daily news, covering the most up to date financial information. The Buzz intends to provide factual and relevant information for its audience. The Buzz is 100% original content, created by Financial Buzz Media. Located on Wall Street in the heart of New York City’s financial district, FinancialBuzz.com is a credible source for the world’s latest trending financial and economic news. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content.